(Q44680441)

5 December 2017

title

Effect of montelukast pretreatment on inducible nitric oxide synthase mRNA expression in the lungs of antigen-challenged allergic mice (English)

1 reference

5 December 2017

Sade K

1

1 reference

5 December 2017

Schwartz I

2

1 reference

5 December 2017

Schwartz D

3

1 reference

5 December 2017

Wolman Y

4

1 reference

5 December 2017

Chernichovski T

5

1 reference

5 December 2017

Fireman E

6

1 reference

5 December 2017

Iaina A

7

1 reference

5 December 2017

Kivity S

8

1 reference

5 December 2017

publication date

1 December 2003

1 reference

Clinical & Experimental Allergy

5 December 2017

published in

1 reference

5 December 2017

volume

33

1 reference

5 December 2017

issue

12

1 reference

5 December 2017

page(s)

1741-1746

1 reference

The L-arginine-nitric oxide pathway

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Increased nitric oxide in exhaled air of asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Expression of inducible nitric oxide in human lung epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Endogenous nitric oxide in allergic airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

The importance of leukotrienes in airway inflammation in a mouse model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Involvement of LTD(4)in allergic pulmonary inflammation in mice: modulation by cysLT(1)antagonist MK-571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Formation and release of nitric oxide from human neutrophils and HL-60 cells induced by a chemotactic peptide, platelet activating factor and leukotriene B4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Regulatory interactions between inducible nitric oxide synthase and eicosanoids in glomerular immune injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Effects of pranlukast, a leukotriene receptor antagonist, on airway inflammation in mild asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Priming of alveolar macrophages by leukotriene D(4): potentiation of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Exhaled nitric oxide following leukotriene E(4) and methacholine inhalation in patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Single-breath nitric oxide measurements in asthmatic patients and smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma: A preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

A rapid method for the assay of nitrate in urine using the nitrate reductase enzyme of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

PGE2 and LTB4 inhibit cytokine-stimulated nitric oxide synthase type 2 expression in isolated rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01798.X

10.1111/J.1365-2222.2003.01798.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference